The World Health Organisation (WHO) is soon going to take a decision on COVAXIN, one of the India made vaccines against the Wuhan virus, also known as the Novel Coronavirus (COVID-19.)
On the 29th of September, the WHO said, they would take the final decision regarding the emergency use listing (EUL) of COVAXIN. The decision regarding the EUL of the Hyderabad based Bharat Biotech International Private Limited manufactured vaccine is expected to be made in October 2021.
It is to be noted, the assessment of documents for COVAXIN is underway. The Hyderabad company submitted an Expression of Interest (EOI) regarding the EUL of COVAXIN on the 19th of April 2021. The approval has been pending since July 2021. The major reason behind the delay is said to be missing documents which have been asked to be submitted. After the assessment of the data, the decision regarding emergency use listing would be taken.
Dr. Bharati Pravin Pawar, the MoS of Health of India said, “There is a procedure of submitting the documents for approval, WHO’s emergency use authorization to COVAXIN is expected soon.”
According to the WHO official website, the Strategic Advisory Group of Experts on Immunisation (SAGE) of WHO would meet on the 5th of October and take a final decision.
As of now, the India made COVAXIN has finished three phase trials and proved efficiency of 77% against the deadly Wuhan virus. With the EUL approval of COVAXIN, travelling for people who received COVAXIN would be easier and would be licensed globally.
As of now, only Covisheild, the second India made COVID-19 vaccine has EUL approval from the WHO. The Serum Institute of India (SII) manufactured Covisheild received EUL approval in February 2021.
Mango News Link
Telegram: https://t.me/mangonewsofficial
Google Play Store: https://bit.ly/2R4cbgN
Apple / iOS Store: https://apple.co/2xEYFJ
